Lin Yu-Hsin
SEC CIK 1965964 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLTE | BELITE BIO, INC | CEO, Dir | 70.1K | — | $20.82M | 4 | 2026-04-09 | 2026-09-04 |
Most active insiders at BLTE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Yu-Hsin | CEO, Dir | — | $20.82M |
| 2 | Chuang Hao-Yuan | CFO, Dir | — | $14.00M |
| 3 | Scholl Hendrik Peter | Chief Medical Off | — | $2.86M |
| 4 | MATA NATHAN L. | CSO | — | $2.67M |
| 5 | Chen Wan-Shan | Dir | — | $198.5K |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-09 19:39 | 2026-09-04+ | BLTE | BELITE BIO, INC | Lin Yu-Hsin | CEO, Dir | S - Sale | $190.00 | -100.4K | 70.1K | -59% | -$19.08M |
| MT | 2026-08-14 06:10 | 2026-08-12 | BLTE | BELITE BIO, INC | Lin Yu-Hsin | CEO, Dir | S - Sale | $180.35 | -365 | 170.6K | -0.2% | -$65.8K |
| 2026-04-23 16:23 | 2026-04-21 | BLTE | BELITE BIO, INC | Lin Yu-Hsin | CEO, Dir | J - Other | $0.00 | +10.0K | 182.9K | +6% | $0 | |
| MT | 2026-04-13 16:15 | 2026-04-09 | BLTE | BELITE BIO, INC | Lin Yu-Hsin | CEO, Dir | S - Sale | $181.45 | -9,200 | 170.9K | -5% | -$1.67M |
Purchase Sale Sale after option exercise All abbreviations